These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Lysozyme in hematologic diseases]. Zittoun J; Zittoun R Sem Hop; 1975 Jan; 51(4):247-52. PubMed ID: 167445 [TBL] [Abstract][Full Text] [Related]
3. Clinical significance of serum and urinary muramidase activity in leukemia and other hematologic malignancies. Wiernik PH; Serpick AA Am J Med; 1969 Mar; 46(3):330-43. PubMed ID: 4888852 [No Abstract] [Full Text] [Related]
4. [Serum lysozyme in some haematological diseases (author's transl)]. Bláha M; Procházková J; Wagenknecht D; Vanásek J; Siroký O Cas Lek Cesk; 1978 Jul; 117(27):827-9. PubMed ID: 278647 [No Abstract] [Full Text] [Related]
5. Serum lysozyme and vitamin B 12 binding capacity in myeloproliferative disorders. Catovsky D; Galton DA; Griffin C; Hoffbrand AV; Szur L Br J Haematol; 1971 Dec; 21(6):661-72. PubMed ID: 5289350 [No Abstract] [Full Text] [Related]
6. Lysozyme in Haematology pathophysiology and clinical use. Hansen NE Scand J Haematol; 1975 May; 14(3):160-5. PubMed ID: 1145118 [No Abstract] [Full Text] [Related]
7. [Serum and urine lysozyme activity in various blood disorders and hypopotassemia in leukemia]. Shimizu M; Takabayashi Y; Asai I; Nishina T; Niwa S Rinsho Ketsueki; 1972 Aug; 13(4):549-59. PubMed ID: 4509361 [No Abstract] [Full Text] [Related]
8. Defective granulocyte regulation in the Chediak-Higashi syndrome. Blume RS; Bennett JM; Yankee RA; Wolff SM N Engl J Med; 1968 Nov; 279(19):1009-15. PubMed ID: 5681251 [No Abstract] [Full Text] [Related]
9. Profile of intracytoplasmic lysozyme in normal tissues, myeloproliferative disorders, hairy cell leukemia, and other pathologic processes. An immunoperoxidase study of paraffin sections and smears. Pinkus GS; Said JW Am J Pathol; 1977 Nov; 89(2):351-66. PubMed ID: 335890 [TBL] [Abstract][Full Text] [Related]
10. [Studies of lysozyme activity in serum, urine and blood smears from patients with haematological diseases]. Labedzki L; Seché G; Lorbacher P Klin Wochenschr; 1977 Jul; 55(14):677-83. PubMed ID: 408556 [TBL] [Abstract][Full Text] [Related]
12. [Lysozyme activities in various leukemias--with special reference to monocytic leukemia]. Ota H; Nagase H Saishin Igaku; 1971 Dec; 26(12):2386-93. PubMed ID: 5290940 [No Abstract] [Full Text] [Related]
13. Muramidase activity in normal and leukemic leukocytes. Dan R; Micu D Rev Roum Med Intern; 1973; 10(4):285-7. PubMed ID: 4743746 [No Abstract] [Full Text] [Related]
16. [Determination of lysozyme and its clinical significance]. Nishina T; Muto Y; Yamaguchi H Rinsho Byori; 1973 Jan; 21(1):37-42. PubMed ID: 4575081 [No Abstract] [Full Text] [Related]
17. [Isoenzymes of fructosephosphate aldolase in the serum of patients with various malignant hemopathies. Isoenzymes of fructosephosphate aldolase. IX]. Dikow AL; Genova V Z Klin Chem Klin Biochem; 1969 Nov; 7(6):614-6. PubMed ID: 4903945 [No Abstract] [Full Text] [Related]
18. [Importance of lysozyme (muramidase) in hematologic studies]. Steytler JG S Afr Med J; 1971 Oct; 45(42):1202-5. PubMed ID: 5288842 [No Abstract] [Full Text] [Related]
19. [Cytochemical studies on beta-glucuronidase in white blood cells in various diseases of the hematopoietic system]. Nilius R; Krosch H; Lötsch V Folia Haematol Int Mag Klin Morphol Blutforsch; 1971; 95(4):389-97. PubMed ID: 4107574 [No Abstract] [Full Text] [Related]